Rankings
▼
Calendar
PHIO Q3 2023 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-10.26
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$89,000
Balance Sheet
Total Assets
$10M
Total Liabilities
$2M
Stockholders' Equity
$7M
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$2M
-$3M
+27.9%
Operating Income
-$3M
-$4M
+22.3%
Net Income
-$3M
-$4M
+22.3%
← FY 2023
All Quarters
Q4 2023 →